Expect a bumpy ride when FDA advisers consider booster shots

Last December, when advisers to the US Food and Drug Administration met to consider whether the agency should authorize Pfizer's Covid-19 vaccine, it was generally understood that the answer would be yes.

Click Here to read the entire article...